Status:
UNKNOWN
The Effect of Ganoderma on Patients With Head-and-neck Cancer
Lead Sponsor:
Chang Bing Show Chwan Memorial Hospital
Conditions:
Head-and-neck Cancer
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
To study the effect of Ganoderma Spores Powder Capsules on the life quality and immunity status of the patients with head-and-neck cancer after complete treatment (including surgery and / or radiother...
Detailed Description
Ganoderma is known to modulate immunity and improve health. However, the mechanism is not clear. We hypothesize that patients who have completed standard treatment with/without radiotherapy might requ...
Eligibility Criteria
Inclusion
- Patients with head-and-neck cancer after complete treatment for at least 3 months (including surgery and/or radiotherapy and/or chemotherapy)
Exclusion
- Patients with head-and-neck cancer under treatment or within 3 months after treatment
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02238587
Start Date
June 1 2014
End Date
May 1 2015
Last Update
September 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Core Laboratory; Chang Bing Show Chwan Memorial Hospital
Changhua County, Taiwan